NCT02273479View on ClinicalTrials.gov

Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

September 30, 1999

Conditions
Healthy
Interventions
DRUG

Asasantin®

Asasantin® extended release (RAD-SP)

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY